Tuesday, September 1, 2026

Fiserv Stock Drops 24% In 10 Sessions: Is It Time To Buy Or Sell?

Fiserv Stock Drops 24% In 10 Sessions: Is It Time To Buy Or Sell?

(VIANEWS) - Since March 18th and closing at EUR152.14 on March 22nd at 10:03 EST on Tuesday at 10:03, shares of Fiserv (NASDAQ: FISV) have dropped 24.92%. Each session, their stock opened higher but declined steadily; closing on Tuesday at 10:03 EST it closed at EUR114.23 following an earlier drop-off session. This downward trend continues each session following. At EUR16,396.83, the NASDAQ index is currently up 0.11% from where it stood prior to last session reversing a trend seen previously in terms of its downward movement. This upward momentum aligns well with market optimism.

Technical Analysis

Fiserv's stock price has been classified as oversold based on a stochastic oscillator reading of =20, as indicated by its reported volume of 2,005,116; significantly more than its average volume of 4,112,350 and signalling high trading activity. Intraday volatility for Fiserv has remained fairly consistent at an average 0.37% over the last week, month, quarter as well as highs amplitude volatility levels such as 0.70% over quarter. Therefore traders should keep an eye out for price levels that may signify shifts in trend indicating potential significant shifts.

Equity Analysis

Earnings Per Share Fiserv has reported a trailing twelve month EPS of EUR3.85. Additionally, Fiserv has an earnings to price ratio of 29.67. Meaning a buyer of shares invests EUR29.67 of annual earnings when investing in Fiserv. Dividend YieldFiserv has an impressive dividend yield of 0.43% indicating it distributes a small portion of earnings to shareholders as dividends. Revenue GrowthFiserv has experienced steady revenue growth over recent years with compound annual compound annual growth rate averaging 5.5% since 2011. This growth is driven by the company's emphasis on expanding digital solutions and investing in innovation. Industry OutlookThe financial technology sector is expected to experience steady expansion due to increasing consumer demand for digital banking services and mobile solutions. Fiserv is well positioned to capitalize on these trends, given its comprehensive portfolio of products and services and strong market position. Fiserv's current price to earnings ratio of 29.67 may seem high when compared against industry norms; however, when considered relative to peers it falls in line. Investors should carefully consider other valuation metrics and the company's growth prospects before making any investment decisions. Risks As with any investment, investing in Fiserv presents some inherent risks. Fiserv presents numerous risks for investors. These include regulatory and compliance risks, technological disruptions and competition from other financial technology companies.Investment OutlookFiserv presents itself as an attractive investment opportunity given its consistent profitability, revenue growth and positive industry outlook. However, investors should carefully consider their own investment goals, risk tolerance and current market conditions before making any final decisions on any investments.

More news about Fiserv (FISV).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com